Nanocarrier-based drug combination therapy for glioblastoma

The current achievements in treating glioblastoma (GBM) patients are not sufficient because many challenges exist, such as tumor heterogeneity, the blood brain barrier, glioma stem cells, drug efflux pumps and DNA damage repair mechanisms. Drug combination therapies have shown increasing benefits ag...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Theranostics
Asıl Yazarlar: Zhao, Mengnan, van Straten, Demian, Broekman, Marike L.D., Préat, Véronique, Schiffelers, Raymond M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Ivyspring International Publisher 2020
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6956816/
https://ncbi.nlm.nih.gov/pubmed/31938069
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.38147
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller